Overview Financials News + Filings Key Docs Ownership Insiders
|
|
Entera Bio Ltd. (ENTX)
|
|
| Common Size Income Statement |
|
|
|
|
Annual | Quarterly | TTM |
|
| In millions, except per share items | Jun-30-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 |
| | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
| Revenues | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Cost of goods sold | | 57.1% | 75.0% | 75.0% | 79.4% | 82.4% | 46.4% | 90.8% |
| Gross profit | | 42.9% | 25.0% | 25.0% | 20.6% | 17.6% | 53.6% | 9.2% |
| Research and development | | 9650.0% | 17662.5% | 3168.2% | 2485.3% | 1605.5% | 1265.0% | 1125.7% |
| General and administrative | | 12435.7% | 18250.0% | 4272.7% | 3192.6% | 898.2% | 1096.4% | 1251.4% |
| EBITDA | | -21800.0% | -35612.5% | -7347.7% | -5616.2% | -2469.1% | -2289.3% | -2344.0% |
| Depreciation | | 114.3% | 200.0% | 36.4% | 23.5% | 8.5% | 10.7% | 13.8% |
| EBIT | | -21914.3% | -35812.5% | -7384.1% | -5639.7% | -2477.6% | -2300.0% | -2357.8% |
| Pre-tax income | | 22007.1% | 35912.5% | 7247.7% | 5575.0% | 2493.9% | 2305.0% | 2379.8% |
| Income taxes | | 328.6% | -2425.0% | 9.1% | 10.3% | 9.1% | 9.3% | 15.6% |
| Net income | | 21678.6% | 38337.5% | 7238.6% | 5564.7% | 2484.8% | 2295.7% | 2364.2% |
|